PPA
STIM icon

Parametric Portfolio Associates’s Neuronetics STIM Stock Holding History

Parametric Portfolio Associates’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$76K Sell
24,991
-10,593
-30% -$35.8K ﹤0.01% 3596
2021
Q4 		$159K Buy
35,584
+137
+0.4% +$671 ﹤0.01% 3464
2021
Q3 		$233K Buy
35,447
+12,848
+57% +$123K ﹤0.01% 3387
2021
Q2 		$362K Buy
22,599
+1,861
+9% +$25.7K ﹤0.01% 3204
2021
Q1 		$257K Sell
20,738
-459
-2% -$7.04K ﹤0.01% 3777
2020
Q4 		$235K Sell
21,197
-4,291
-17% -$32.3K ﹤0.01% 3706
2020
Q3 		$124K Sell
25,488
-7,484
-23% -$28.4K ﹤0.01% 3753
2020
Q2 		$64K Buy
32,972
+12,843
+64% +$26.3K ﹤0.01% 3839
2020
Q1 		$38K Buy
20,129
+9,681
+93% +$30.3K ﹤0.01% 3862
2019
Q4 		$47K Buy
+10,448
New +$64.9K ﹤0.01% 3924

Other funds holding STIM

CC
Cannell Capital Alta, Wyoming $149M AUM 39.81% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return

Parametric Portfolio Associates's STIM Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Neuronetics (STIM) stake by 30% in Q1 2022, selling an estimated $35.8K and leaving 24,991 shares worth $76K. The position accounts for ﹤0.01% of the portfolio, ranked #3596.

Parametric Portfolio Associates first reported a position in STIM in Q4 2019 and has held it in 10 quarters since. The position peaked at $362K in Q2 2021. 83 funds tracked by Wall St. Rank hold STIM as of Q1 2022.

  • Parametric Portfolio Associates held 24,991 shares of Neuronetics worth $76K as of Q1 2022.
  • Parametric Portfolio Associates sold 10,593 Neuronetics shares in Q1 2022, an estimated $35.8K.
  • Neuronetics made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3596 holding.
  • Parametric Portfolio Associates first reported a position in Neuronetics in Q4 2019 and has held it in 10 quarters since.
  • Parametric Portfolio Associates's Neuronetics position peaked at $362K in Q2 2021.
  • 83 funds tracked by Wall St. Rank held Neuronetics as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.